Literature DB >> 32551283

A Study on Role of NOSE Scale in the Management of Allergic Rhinitis.

Angshuman Dutta1, Srujan Vallur1, A P Arjun1, Lovraj Goyal1.   

Abstract

Allergic rhinitis is a global health problem and patients present with varied symptoms. The severity of symptoms is evaluated by a 5 point Nasal Obstruction Symptom Evaluation Scale (NOSE) and levels of absolute eosinophil count (AEC). A prospective observational study was conducted in 140 patients in a tertiary care hospital over a period of 1 year. A detailed clinical examination was performed, NOSE scale scoring based on symptomatology was done, and AEC values were assessed. Subjects were treated with intra nasal steroid spray and symptom evaluation done by NOSE scale at 3 months of use for follow up. NOSE scale and AEC values were correlated in our study. The mean NOSE 1 scale was 64.07 ± 16.71 in the study population, the mean AEC value was 633.07 ± 152.77. In our study correlation between intra nasal steroid spray and NOSE scale has been done. NOSE scale evaluation is simple, economical, and non-invasive. Therefore, it may be used in the management of allergic rhinitis. © Association of Otolaryngologists of India 2020.

Entities:  

Keywords:  Absolute eosinophil count (AEC); Allergic rhinitis (AR); Nasal obstruction symptom evaluation (NOSE) scale; Steroid nasal spray

Year:  2020        PMID: 32551283      PMCID: PMC7276453          DOI: 10.1007/s12070-020-01794-0

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  8 in total

1.  Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale.

Authors:  Michael G Stewart; David L Witsell; Timothy L Smith; Edward M Weaver; Bevan Yueh; Maureen T Hannley
Journal:  Otolaryngol Head Neck Surg       Date:  2004-02       Impact factor: 3.497

2.  Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis.

Authors:  Philipp Badorrek; Jens M Hohlfeld; Norbert Krug; Abhijeet Joshi; Atul Raut
Journal:  Ann Allergy Asthma Immunol       Date:  2015-08-11       Impact factor: 6.347

Review 3.  Rhinitis and sinusitis.

Authors:  Mark S Dykewicz; Daniel L Hamilos
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

4.  Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.

Authors:  M Innes Asher; Stephen Montefort; Bengt Björkstén; Christopher K W Lai; David P Strachan; Stephan K Weiland; Hywel Williams
Journal:  Lancet       Date:  2006-08-26       Impact factor: 79.321

Review 5.  Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis.

Authors:  M Okano
Journal:  Clin Exp Immunol       Date:  2009-08-06       Impact factor: 4.330

Review 6.  Systemic effects of local allergic disease.

Authors:  Alkis Togias
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

7.  Management of rhinitis: allergic and non-allergic.

Authors:  Nguyen P Tran; John Vickery; Michael S Blaiss
Journal:  Allergy Asthma Immunol Res       Date:  2011-05-20       Impact factor: 5.764

Review 8.  The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.

Authors:  Leif Bjermer; Marit Westman; Mats Holmström; Magnus C Wickman
Journal:  Allergy Asthma Clin Immunol       Date:  2019-04-16       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.